Anorexic and bulimic eating disorders

被引:0
作者
Fichter, MM [1 ]
机构
[1] Univ Munich, Klin Psychiat & Psychotherapie, Munich, Germany
来源
NERVENARZT | 2005年 / 76卷 / 09期
关键词
eating disorders; anorexia nervosa; bulimia; nervosa; binge-eating disorder;
D O I
10.1007/s00115-005-1976-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Anorexic and bulimic eating disorders today are rather frequent in adolescent girls and young women of developed industrial countries. News media frequently report such patients, and lay people are interested. For scientists, it is not easy to explain the etiology and pathophysiology of these eating disorders. Clinically, treatment is a challenge. General risk factors for the development of anorexic and bulimic eating disorders are (1) female gender, (2) adolescence, and (3) living in an industrial country. Special risk factors are (1) obesity or mental disorders (eating, depression, substance use), (2) premorbid characteristics (early menarche, childhood obesity, anxiety disorder, low self-esteem, and perfectionism), and (3) premorbid stresses. Biological and sociocultural factors and personally threatening experiences all play a role in the etiology. Especially in early phases of the illness, affected patients do not appear to suffer, are reluctant to admit symptoms, and may avoid necessary treatment. Progress has recently been made in the understanding and treatment of anorexic and bulimic eating disorders.
引用
收藏
页码:1141 / 1153
页数:13
相关论文
共 10 条
  • [1] [Anonymous], 2000, Am J Psychiatry, V157, P1
  • [2] [Anonymous], 2004, EAT DIS COR INT TREA
  • [3] BERGMAN DR, 2003, P 28 INT COSM RAY C, V1, P397
  • [4] Eating disorders
    Fairburn, CG
    Harrison, PJ
    [J]. LANCET, 2003, 361 (9355) : 407 - 416
  • [5] Fichter M., 1999, SIAB STRUKTURIERTES
  • [6] Twelve-year course and outcome of bulimia nervosa
    Fichter, MM
    Quadflieg, N
    [J]. PSYCHOLOGICAL MEDICINE, 2004, 34 (08) : 1395 - 1406
  • [7] FICHTER MM, 2005, THERAPIE PSYCHIATRIC
  • [8] FICHTER MM, 2000, PRAXISLEITLINIEN PSY, V4
  • [9] Effects of recombinant human IGF-1 and oral contraceptive administration on bone density in anorexia nervosa
    Grinspoon, S
    Thomas, L
    Miller, K
    Herzog, D
    Klibanski, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) : 2883 - 2891
  • [10] Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa
    Kaye, WH
    Nagata, T
    Weltzin, TE
    Hsu, LG
    Sokol, MS
    McConaha, C
    Plotnicov, KH
    Weise, J
    Deep, D
    [J]. BIOLOGICAL PSYCHIATRY, 2001, 49 (07) : 644 - 652